• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

solvay

  1. Worst company ever and Gonzalez is a joke

    There is certainly a culture there where they'll punish you if your not wanted or someone wants a, "Friend" in that place. Solvay legacy manager's are the most incompetent of all here. They promote people who can't sell their way out of a paper bag but, can sure play politics. Gonzalez just...